Is MEDVi the same as tirzepatide?

Is MEDVi the drug tirzepatide?

No. Tirzepatide is the name of a drug ingredient, while MEDVi is the provider or program being evaluated. The ingredient may be discussed in a service’s materials without identifying the finished medicine, current stock, or actual prescription offered to a patient. Confirm those details from the clinician and pharmacy rather than using the company name as a medication label.

What the company actually does

MEDVi presents an online platform with provider review and pharmacy fulfillment. Its public disclosure names OpenLoop Health and CareGLP-affiliated professional entities in connection with medical care, and identifies several pharmacy partners. Those are provider disclosures, not a license audit conducted by this publication.

A material part of this review is the FDA’s February 20, 2026 warning letter addressed to MEDVi, LLC. The letter concerns misleading marketing of compounded semaglutide and tirzepatide, including product labeling and claims that could imply approval. The existence of a real business does not remove those concerns.

The prescription and pharmacy

MEDVi’s current public footer lists Triad Rx, Red Rock, and Beaker among its pharmacy partners. A partner list does not identify which pharmacy will fill a particular patient’s order or verify its authority to ship into that patient’s state.

The FDA letter concerns GLP-1 marketing reviewed in December 2025. It should not be generalized into a finding about every MEDVi product or every patient. We have not established a later FDA closeout in the materials used for this review, and we do not assume the warning has been resolved.

Safety is specific to the treatment

Where a plan uses compounded medication, the product is not FDA-approved. A medical assessment should consider your conditions, current prescriptions, past reactions, and the exact formulation. An approved product’s research does not automatically establish the performance of a compounded version.

The more focused MEDVi safety guide explains how the provider’s disclosures fit the medication questions. For the underlying distinction, see compounded GLP-1 drugs and FDA approval.

Cancellation and refund details

The main site links to terms and a refund policy. Some linked legal destinations did not load successfully during this research, so we cannot certify their current contents. Ask support for a working policy URL or a copy of the terms before committing to a prepaid plan.

For an existing charge, identify whether the issue is cancelling future service, requesting a refund, or stopping an unfilled order. Ask support to document the prescription stage and the exact policy relied on. A failure to retrieve a document is a verification gap, not proof that the company has no policy.

Keep the plan terms with your receipt. Our MEDVi cancellation guide separates ending future service from asking for money back.

Tirzepatide is an ingredient; the finished product still matters

Two FDA-approved brands containing tirzepatide are Zepbound and Mounjaro. Their labels describe specific products, uses, and precautions. A compounded preparation is not automatically one of those products, and it is not appropriately described as an FDA-approved generic version merely because it contains the ingredient. FDA does not evaluate compounded medicines for safety, effectiveness, and quality before marketing.

For a proposed prescription through MEDVi, ask for the complete name, formulation, concentration where relevant, and dispensing pharmacy. A clinician can explain why the specific treatment is being considered. The pharmacist can explain the exact preparation and written directions. Product approval, pharmacy status, and personal suitability are different questions; a statement about one should not be stretched into a conclusion about all three.

What to compare before enrolling or switching

Ask whether the displayed fee covers assessment, ongoing clinical access, medicine, or a combination. If a prescription is filled at an outside pharmacy, obtain that separate price and confirm the fill can proceed. A low program fee does not prove that the requested branded medicine is included. Also establish what happens if the clinician does not recommend the product you requested.

If you currently take medication, share the prescription and pharmacy label with the receiving clinician. Include recent use and any gap in treatment. Do not reuse measurements from a different concentration or combine instructions from different products. Ask who handles follow-up and how the existing account or order should be closed. Our MEDVi review provides the broader service record so this ingredient question can be considered alongside the actual care and purchase arrangements.